Article info

Protocol
Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

Authors

  1. Correspondence to Caroline Nørgaard-Pedersen; c.noergaardpedersen{at}rn.dk
View Full Text

Citation

Nørgaard-Pedersen C, Nielsen K, Steffensen R, et al
Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

Publication history

  • Received May 16, 2022
  • Accepted September 8, 2022
  • First published September 22, 2022.
Online issue publication 
March 27, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.